Investigator Satisfaction Survey Marketing department

Transcription

1 Investigator Satisfaction Survey 2005 Marketing department 1

2 Who answered the questionnaire? How do investigators usually contact Clirophtha? Our clinical research activity E-CRFs What do investigators think about Clirophtha? Some investigator s comments 2

3 Who answered the questionnaire? 22% 13% Clirophtha wanted to know the investigator s opinion to improve it s services quality. An anonymous questionnaire was sent by and by fax to 362 ophthalmologists, 2 orthoptists and 16 study nurses which represent 82% of our data base. 0-1 years 1-2 years 2-5 years Fig 1. Date of the last trial done with Clirophtha 65% 13% answered the questionnaire. The investigators who answered the questionnaire have a large experience in clinical research: on average, they do 17.1 trials per investigator and 71.4% of them have been doing trials for more than ten years. 65% of them did their last trial with Cirophtha this year (fig 1). 3

4 Contact with Clirophtha? The phone stills the most frequent way to contact Clirophtha and the use of the e- mail is in progress (fig 2). satisfaction 10 8 importance % phone 40% fax 29% Fig2. The ways to contact Clirophtha 10,0 8,0 6,0 4,0 2,0 0,0 2 0 quality facility speed Fig 3. The phone contact quality 2-5 years 1-2 years 0-1 years quality facility speed Fig 4. The satisfactin of the investigators of our phone reception since 5 years Almost all investigators appreciated the quality of our phone reception and found that their requests are treated quickly (fig 3). The investigators are more and more pleased to call us. Indeed, they noticed that it is easier to contact us nowadays than five years ago, and that their requests are treated faster and easier (fig 4). 4

5 Our clinical research activity CRA activity Monitoring quality Scientific skills mark 8,6 7,8 Clirophtha has a very good quality of clinical research activity. In fact, 98% of investigators enjoy working with our CRA s. They especially like the monitoring quality and the interpersonal exchange with them. (fig 5). Fig 6. Investigator s satisfaction according to the date of their last trial with Clirophtha 100% 80% 60% 40% 20% 0% monitoring Scientific skills Facility of contact availability Interpersonal exchange 0-1 year 1-2 years 2-5 years The respect of your engagements Regular contact Facility of contact availability Interpersonal exchange The respect of your engagements Regular contact General mark All investigators, whenever they did their last trial with Clirophtha, are very satisfied with our CRA s activity. Investigators who did their last trial more than one year ago, keep a good souvenir of our CRAs (fig 6). 8,1 8,3 8,4 8,1 8,2 8,2 Fig 5. Investigator s satisfaction of CRA s 5

6 Our clinical research activity Clirophtha provides also documents of a very good quality. 100% of investigators think that the clarity of all the documents meets their expectations. (fig 7). clarity 10 importance protocol summary informed consent 0 CRF synopsis Investigator brochure 9,0 8,5 8,4 7,4 7,1 6,8 Fig 7. The quality of our documents protocol CRF summary Informed consent Investigator brochure synopsis Fig 8. The importance of documents occording to the investigators Investigators concider that the clarity of the protocol, the CRF and the summary is the most important(fig 8). 6

7 E-CRFs Clirophtha 32% 30% of investigators have already used an electronic CRF (e-crf). 32 % of them used it in trials managed by Clirophtha (fig 9). No 33% Yes 67% Fig 10. Investigators who are in favor to e-crfs Data privacy 15% Difficulty 8% with e-crf 31% Lack of time Control of computers 12% Fig 11. Reasons of refusal of e-crfs 34% Internet connection 68% Other CROs Fig 9. The use of e-crfs in Clirophtha 67% of investigators are in favor to the use of e-crfs (fig 10). Most of investigators unwilling to e-crfs have problems with the internet connection at the site of investigation or think that it takes too much time. (fig 11). In Clirophtha, we think that people who use usually e- mails to communicate are more in favor to e-crfs than others. Precisely, 74% of them find it is a good idea. 79% of investigators who already used e-crfs, are tempted to try it again. Most of others are not comfortable with computrs or don t trust data privacy. 7

8 What do investigators think about Clirophtha? 23% of trials conduct by the investigators are managed by Clirophtha (fig 12). clirophtha 23% CRFs in English remuneration Experience in clinical research 5,4 8,2 5,4 Spcialization in ophthalmology 7,3 The size of the company 8,7 8,3 7,5 Staff s dynamisme Regulatory skills 7,8 Studie s organisation 8,5 Staff s motivation 77% other CROs and pharmaceuticals Fig 12. Clirophtha trial part 98% of investigators are satisfied with trials managed by Clirophtha. They also thought that the specialization in ophthalmology is an asset to Clirophtha (fig 13). Fig 13. Clirophtha s competence 8

9 What do investigators think about Clirophtha? 100% of investigators who wanted to continue doing clinical research, wish to continue working with Clirophtha (fig 14). 95% of investigators would recommend Clirophtha to pharmaceutical laboratories and 98% would advise other ophthalmologists to do clinical trials with us (fig 14). 100% 80% 60% 40% 20% 0% Continue clinical trials with Clirophtha Recommend Clirophnta to collegues Recommend Clirophtha to laboratories yes no Fig 14 9

10 Some investigator s comments «It s always a pleasure to work with Clirophtha» «Bravo! Continue.» My experience with Clirophtha is quiet old, but I still have a good souvenir of it. I am very satisfied of your CRAs «I had a very nice experience in the experimental trial I did for Clirophtha» A very pleasant contact with CRAs CRAs and investigators don t have always the same goals, their relations are sometimes delicate. 10

11 Clirophtha thanks all the investigators for their collaboration and will be pleased to work with them again. ZI les Nertières, Allée Hector Pintus, La Gaude tel: , fax: info@clirophtha.com 11